Clinical Trial Update: Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial of pIL-12 electroporation in head and neck squamous cell carcinoma was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• pIL-12 electroporation (interleukin-12 delivered by electroporation)

Snippet

Sponsor: OncoSec Medical Incorporated | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2018-01-03